To hear about similar clinical trials, please enter your email below
Trial Title:
Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
NCT ID:
NCT06260410
Condition:
Prostate Cancer Metastatic
Conditions: Official terms:
Prostatic Neoplasms
Conditions: Keywords:
mCRPC
Lu-PSMA
Prostate Cancer
Radioligand Therapy
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
Blood draw for ctDNA and circulating tumor cell collection.
Description:
During routine blood sample collection, additional blood will be drawn for analysis of
ctDNA and to collect Circulating Tumor Cells.
Summary:
This prospective study aims to collect data and blood biomarkers from patients undergoing
Lu-PSMA therapy at the Erasmus MC. In doing so, it will provide real-world efficacy and
safety data on the drug, gather dosimetry data and explore putative biomarkers to
identify patients who most benefit from Lu-PSMA treatment.
Criteria for eligibility:
Study pop:
Patients diagnosed with metastatic castration resistant prostate cancer set to receive
treatment with Lutetium-177 Prostate Specific Membrane Antigen (Lu-PSMA) as a part of
regular clinical care.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Participants should be at least 18 years old.
- Participants should be able to understand the written information and be able to
provide informed consent.
- Participants are planned to start treatment with Lu-PSMA as a part of regular
clinical care.
Exclusion Criteria:
None applicable
Gender:
Male
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Erasmus MC
Address:
City:
Rotterdam
Zip:
3015 CN
Country:
Netherlands
Status:
Recruiting
Contact:
Last name:
Stijn Koolen, PhD
Phone:
+31638740656
Email:
s.koolen@erasmusmc.nl
Start date:
February 20, 2024
Completion date:
February 1, 2027
Lead sponsor:
Agency:
Erasmus Medical Center
Agency class:
Other
Source:
Erasmus Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06260410
